Solexa, Inc. Letterhead]Board of Directors Representative Agreement • April 26th, 2005 • Solexa, Inc. • Medicinal chemicals & botanical products
This purpose of this letter is to confirm the understanding between Solexa, Inc., a Delaware company (the “Company”)and ValueAct Capital Master Fund, L.P. (“ValueAct”) in connection with the Company’s private placement of common stock and warrants pursuant to that certain Securities Purchase Agreement, dated April 21, 2005, by and between the Company and the individuals and entities identified on the signature pages hereto (the “Purchase Agreement”).
